Furthermore, targeting KDM4 (demethylase for H3K9 and H3K36) may be used to overcome cetuximab resistance in CRC with high EGFR gene copy number, since inhibiting KDM4 reduced EGFR amplifications in CRC cells [175]. This evidence concerns the gene EGFR and colorectal carcinoma.